230 related articles for article (PubMed ID: 31473246)
1. Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation.
Tanner MA; Thomas TP; Grisanti LA
J Mol Cell Cardiol; 2019 Nov; 136():1-14. PubMed ID: 31473246
[TBL] [Abstract][Full Text] [Related]
2. β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.
Grisanti LA; Talarico JA; Carter RL; Yu JE; Repas AA; Radcliffe SW; Tang HA; Makarewich CA; Houser SR; Tilley DG
J Mol Cell Cardiol; 2014 Jul; 72():39-51. PubMed ID: 24566221
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Clerk A; Meijles DN; Hardyman MA; Fuller SJ; Chothani SP; Cull JJ; Cooper STE; Alharbi HO; Vanezis K; Felkin LE; Markou T; Leonard SJ; Shaw SW; Rackham OJL; Cook SA; Glennon PE; Sheppard MN; Sembrat JC; Rojas M; McTiernan CF; Barton PJ; Sugden PH
Biochem J; 2022 Feb; 479(3):401-424. PubMed ID: 35147166
[TBL] [Abstract][Full Text] [Related]
5. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy.
Li Y; Zhang H; Liao W; Song Y; Ma X; Chen C; Lu Z; Li Z; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1941-51. PubMed ID: 21856923
[TBL] [Abstract][Full Text] [Related]
6. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
Guo X; Meng Y; Sheng X; Guan Y; Zhang F; Han Z; Kang Y; Tai G; Zhou Y; Cheng H
Anticancer Drugs; 2017 Jan; 28(1):66-74. PubMed ID: 27603596
[TBL] [Abstract][Full Text] [Related]
7. Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophy.
Smith NJ; Chan HW; Qian H; Bourne AM; Hannan KM; Warner FJ; Ritchie RH; Pearson RB; Hannan RD; Thomas WG
Hypertension; 2011 May; 57(5):973-80. PubMed ID: 21383310
[TBL] [Abstract][Full Text] [Related]
8. Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.
Grisanti LA; Repas AA; Talarico JA; Gold JI; Carter RL; Koch WJ; Tilley DG
Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H316-30. PubMed ID: 25485901
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
10. A Dual Role for Death Receptor 5 in Regulating Cardiac Fibroblast Function.
Tanner MA; Grisanti LA
Front Cardiovasc Med; 2021; 8():699102. PubMed ID: 34527710
[TBL] [Abstract][Full Text] [Related]
11. Dual Agonist Surrobody Simultaneously Activates Death Receptors DR4 and DR5 to Induce Cancer Cell Death.
Milutinovic S; Kashyap AK; Yanagi T; Wimer C; Zhou S; O'Neil R; Kurtzman AL; Faynboym A; Xu L; Hannum CH; Diaz PW; Matsuzawa S; Horowitz M; Horowitz L; Bhatt RR; Reed JC
Mol Cancer Ther; 2016 Jan; 15(1):114-24. PubMed ID: 26516157
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity.
Uberti D; Ferrari-Toninelli G; Bonini SA; Sarnico I; Benarese M; Pizzi M; Benussi L; Ghidoni R; Binetti G; Spano P; Facchetti F; Memo M
Neuropsychopharmacology; 2007 Apr; 32(4):872-80. PubMed ID: 16936710
[TBL] [Abstract][Full Text] [Related]
13. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
14. PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation.
Mendez M; LaPointe MC
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2111-7. PubMed ID: 15626689
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
16. Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility.
Sabri A; Wilson BA; Steinberg SF
Circ Res; 2002 May; 90(8):850-7. PubMed ID: 11988485
[TBL] [Abstract][Full Text] [Related]
17. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
Jayasooriya RG; Choi YH; Hyun JW; Kim GY
Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
[TBL] [Abstract][Full Text] [Related]
18. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
Bui HTT; Le NH; Le QA; Kim SE; Lee S; Kang D
Int J Med Sci; 2019; 16(11):1412-1423. PubMed ID: 31673231
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
Kim SL; Min IS; Park YR; Lee ST; Kim SW
Int J Oncol; 2018 Dec; 53(6):2789-2799. PubMed ID: 30221676
[TBL] [Abstract][Full Text] [Related]
20. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]